Tag: tumours

AI/ML

Inframammary approach for addressing anterior mediastinal tumours: initial experience.

Newsemia
Related Articles Inframammary approach for addressing anterior mediastinal tumours: initial experience. J Thorac Dis. 2020 May;12(5):2077-2081 Authors: Ferreira R, Junqueira N, Rodrigues M, Nobre Â...
Pharma / Biotech

Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours – Results from daily clinical practice.

Newsemia
Related Articles Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours – Results from daily clinical practice. Eur J Cancer. 2020 Jul 17;136:140-148...
Latest News

Multidrug resistance in paediatric solid tumours: identification and potential reversal

Newsemia
Cowie, Fiona Jane; (1995) Multidrug resistance in paediatric solid tumours: identification and potential reversal. Doctoral thesis (M.D), UCL (University College London). Green open access Source...
Latest News

Ex vivo chemosensitivity of melanoma and other solid tumours

Newsemia
Neale, Michael Howard; (2001) Ex vivo chemosensitivity of melanoma and other solid tumours. Doctoral thesis (Ph.D), UCL (University College London). Green open access Source link...
Latest News

Recombinant antibody fragments to vascular associated targets of human tumours

Newsemia
Rubins, Leigh Ruth; (2001) Recombinant antibody fragments to vascular associated targets of human tumours. Doctoral thesis (Ph.D), UCL (University College London). Green open access Source...
Latest News

Programmed cell death ligands expression drives immune tolerogenesis across the diverse subtypes of neuroendocrine tumours

Newsemia
Pinato, DJ; Vallipuram, A; Evans, JS; Wong, C; Zhang, H; Brown, M; Dina, RE; … Sharma, R; + view all Pinato, DJ; Vallipuram, A; Evans,...
Pharma / Biotech

A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours.

Newsemia
Related Articles A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours. Cancer Chemother Pharmacol. 2020 Feb 01;:...
Pharma / Biotech

Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.

Newsemia
Related Articles Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Lancet Oncol. 2019...
Latest News

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Newsemia
Colombo, N; Sessa, C; du Bois, A; Ledermann, J; McCluggage, WG; McNeish, I; Morice, P; … Zeimet, AG; + view all Colombo, N; Sessa, C;...
Latest News

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Newsemia
Colombo, N; Sessa, C; du Bois, A; Ledermann, J; McCluggage, WG; McNeish, I; Morice, P; … ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, .; +...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World